Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ismaheel O Lawal

Showing results (1-10 of 77) with videos related to

Pageof 8
Sort By:
World Journal of Nuclear Medicine|May 24, 2023
Nuclear Medicine Training: Skills and Competencies Required for Practice in the 21st CenturyIsmaheel O Lawal
AJR. American Journal of Roentgenology|February 5, 2025
Radioactive Iodine in Intermediate-Risk Disease, Remnant Ablation, and Adjuvant Treatment: Counterpoint-High Dose for Improved Treatment OutcomeIsmaheel O Lawal, Saima Muzahir
AJR. American Journal of Roentgenology|April 16, 2025
Beyond the <i>AJR</i>: Is Molecular Imaging With <sup>11</sup>C-Metomidate PET/CT a Suitable Noninvasive Alternative to Adrenal Vein Sampling for Detecting Surgically Curable Primary Aldosteronism?Ismaheel O Lawal, David M Schuster
Clinical Nuclear Medicine|May 11, 2026
Response to the Comment on "Negative 18F-FES PET/CT Despite Estrogen Receptor Positivity By Immunohistochemistry."Ismaheel O Lawal, David A Mankoff, David M Schuster
Seminars in Nuclear Medicine|July 26, 2022
Molecular Imaging of TuberculosisIsmaheel O Lawal, Sofiullah Abubakar, Alfred O Ankrah, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 30, 2018
The optimal TSH level necessary for successful radioiodine ablation of differentiated thyroid carcinoma, as well as the time to reach this level, is a work in progressIsmaheel O Lawal, Mariza Vorster, Alfred O Ankrah, et al.
Seminars in Nuclear Medicine|September 13, 2025
Radiolabeled Antibody-Drug Conjugates in the Treatment of Solid TumorsIsmaheel O Lawal, Sofiullah Abubakar, Honest Ndlovu, et al.
Current Opinion in Urology|October 24, 2019
Prostate-specific membrane antigen-targeted endoradiotherapy in metastatic prostate cancerIsmaheel O Lawal, Frank Bruchertseifer, Mariza Vorster, et al.
Nuclear Medicine and Molecular Imaging|December 24, 2019
68Ga-PSMA: a One-stop Shop in Radioactive Iodine Refractory Thyroid Cancer?Thabo Lengana, Ismaheel O Lawal, Kgomotso Mokoala, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 17, 2021
Correction to: Global experience with PSMA‑based alpha therapy in prostate cancerMike M Sathekge, Frank Bruchertseifer, Mariza Vorster, et al.
Pageof 8

Showing results (1-10 of 77) with videos related to

Sort By:
Pageof 8
World Journal of Nuclear Medicine|May 24, 2023
Nuclear Medicine Training: Skills and Competencies Required for Practice in the 21st CenturyIsmaheel O Lawal
AJR. American Journal of Roentgenology|February 5, 2025
Radioactive Iodine in Intermediate-Risk Disease, Remnant Ablation, and Adjuvant Treatment: Counterpoint-High Dose for Improved Treatment OutcomeIsmaheel O Lawal, Saima Muzahir
AJR. American Journal of Roentgenology|April 16, 2025
Beyond the <i>AJR</i>: Is Molecular Imaging With <sup>11</sup>C-Metomidate PET/CT a Suitable Noninvasive Alternative to Adrenal Vein Sampling for Detecting Surgically Curable Primary Aldosteronism?Ismaheel O Lawal, David M Schuster
Clinical Nuclear Medicine|May 11, 2026
Response to the Comment on "Negative 18F-FES PET/CT Despite Estrogen Receptor Positivity By Immunohistochemistry."Ismaheel O Lawal, David A Mankoff, David M Schuster
Seminars in Nuclear Medicine|July 26, 2022
Molecular Imaging of TuberculosisIsmaheel O Lawal, Sofiullah Abubakar, Alfred O Ankrah, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 30, 2018
The optimal TSH level necessary for successful radioiodine ablation of differentiated thyroid carcinoma, as well as the time to reach this level, is a work in progressIsmaheel O Lawal, Mariza Vorster, Alfred O Ankrah, et al.
Seminars in Nuclear Medicine|September 13, 2025
Radiolabeled Antibody-Drug Conjugates in the Treatment of Solid TumorsIsmaheel O Lawal, Sofiullah Abubakar, Honest Ndlovu, et al.
Current Opinion in Urology|October 24, 2019
Prostate-specific membrane antigen-targeted endoradiotherapy in metastatic prostate cancerIsmaheel O Lawal, Frank Bruchertseifer, Mariza Vorster, et al.
Nuclear Medicine and Molecular Imaging|December 24, 2019
68Ga-PSMA: a One-stop Shop in Radioactive Iodine Refractory Thyroid Cancer?Thabo Lengana, Ismaheel O Lawal, Kgomotso Mokoala, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 17, 2021
Correction to: Global experience with PSMA‑based alpha therapy in prostate cancerMike M Sathekge, Frank Bruchertseifer, Mariza Vorster, et al.
Pageof 8